Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Grzybicki, Dana Marie
and
Moore, Steven A.
1999.
Implications of Prognostic Markers in Brain Tumors.
Clinics in Laboratory Medicine,
Vol. 19,
Issue. 4,
p.
833.
Korshunov, Andrey
Timirgaz, Valery
and
Golanov, Andrey
1999.
Prognostic value of aberrant p53 immunoexpression for the recurrence of ependymoma: An analysis of 76 cases.
Neuropathology,
Vol. 19,
Issue. 4,
p.
380.
Kaye, Andrew H.
and
Walker, David G.
2000.
Low grade astrocytomas: controversies in management.
Journal of Clinical Neuroscience,
Vol. 7,
Issue. 6,
p.
475.
Nieder, C.
Petersen, S.
Petersen, C.
and
Thames, H.D.
2000.
The challenge of p53 as prognostic and predictive factor in gliomas.
Cancer Treatment Reviews,
Vol. 26,
Issue. 1,
p.
67.
Bortolotto, Simona
Chiad�-Piat, Loredana
Cavalla, Paola
Bosone, Ivana
Chi�, Adriano
Mauro, Alessandro
and
Schiffer, Davide
2000.
CDKN2A/p16 inactivation in the prognosis of oligodendrogliomas.
International Journal of Cancer,
Vol. 88,
Issue. 4,
p.
554.
Saito, Hidekazu
Saito, Takakazu
Kaneko, Tomoko
Sasagawa, Isoji
Kuramoto, Takeshi
and
Hiroi, Masahiko
2000.
Relatively poor oocyte quality is an indication for intracytoplasmic sperm injection.
Fertility and Sterility,
Vol. 73,
Issue. 3,
p.
465.
Korshunov, Andrey
Golanov, Andrey
and
Timirgaz, Valery
2000.
Immunohistochemical markers for intracranial ependymoma recurrence.
Journal of the Neurological Sciences,
Vol. 177,
Issue. 1,
p.
72.
Reis-Filho, Jorge S.
Faoro, Leonardo N.
Carrilho, Carla
Bleggi-Torres, Luiz F.
and
Schmitt, Fernando C.
2000.
Evaluation of cell proliferation, epidermal growth factor receptor, and bcl-2 immunoexpression as prognostic factors for patients with world health organization grade 2 oligodendroglioma.
Cancer,
Vol. 88,
Issue. 4,
p.
862.
van den Bent, Martin J
2001.
New perspectives for the diagnosis and treatment of oligodendroglioma.
Expert Review of Anticancer Therapy,
Vol. 1,
Issue. 3,
p.
348.
Perry, Arie
2001.
Oligodendroglial Neoplasms: Current Concepts, Misconceptions, and Folklore.
Advances in Anatomic Pathology,
Vol. 8,
Issue. 4,
p.
183.
Bosone, Ivana
Cavalla, Paola
Chiadò‐Piat, Loredana
Vito, Nicoletta Di
and
Schiffer, Davide
2001.
Cyclin D1 expression in normal oligodendroglia and microglia cells: Its use in the differential diagnosis of oligodendrogliomas.
Neuropathology,
Vol. 21,
Issue. 3,
p.
155.
Keles, G. Evren
Lamborn, Kathleen R.
and
Berger, Mitchel S.
2001.
Low-grade hemispheric gliomas in adults: a critical review of extent of resection as a factor influencing outcome.
Journal of Neurosurgery,
Vol. 95,
Issue. 5,
p.
735.
Grzybicki, Dana Marie
Liu, Yulin
Moore, Steven A.
Brown, Henry G.
Silverman, Jan F.
D'Amico, Frank
and
Raab, Stephen S.
2001.
Interobserver variability associated with the MIB-1 labeling index.
Cancer,
Vol. 92,
Issue. 10,
p.
2720.
Fortin, David
Macdonald, David. R.
Cairncross, J. Gregory
and
Stitt, Larry
2001.
PCV for Oligodendroglial Tumors: In Search of Prognostic Factors for Response and Survival.
Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques,
Vol. 28,
Issue. 3,
p.
215.
Bauman, Glenn S.
and
Cairncross, J. Gregory
2001.
Multidisciplinary management of adult anaplastic oligodendrogliomas and anaplastic mixed oligo-astrocytomas.
Seminars in Radiation Oncology,
Vol. 11,
Issue. 2,
p.
170.
Walker, David G
and
Kaye, Andrew H
2001.
Diagnosis and management of astrocytomas, oligodendrogliomas and mixed gliomas: A review.
Australasian Radiology,
Vol. 45,
Issue. 4,
p.
472.
Korshunov, Andrey
and
Golanov, Andrey
2001.
The Prognostic Significance of DNA Topoisomerase II-alpha (Ki-S1), p21/Cip-1, and p27/Kip-1 Protein Immunoexpression in Oligodendrogliomas.
Archives of Pathology & Laboratory Medicine,
Vol. 125,
Issue. 7,
p.
892.
Engelhard, Herbert H
Stelea, Ana
and
Cochran, Elizabeth J
2002.
Oligodendroglioma: pathology and molecular biology.
Surgical Neurology,
Vol. 58,
Issue. 2,
p.
111.
Korshunov, Andrey
and
Golanov, Andrey
2002.
Immunohistochemical Analysis of p18INK4C and p14ARF Protein Expression in 117 Oligodendrogliomas.
Archives of Pathology & Laboratory Medicine,
Vol. 126,
Issue. 1,
p.
42.
Yeh, Shyh-An
Lee, Tao-Chen
Chen, Han-Jung
Lui, Chun-Chung
Sun, Li-Min
Wang, Chong-Jong
and
Huang, Eng-Yen
2002.
Treatment outcomes and prognostic factors of patients with supratentorial low-grade oligodendroglioma.
International Journal of Radiation Oncology*Biology*Physics,
Vol. 54,
Issue. 5,
p.
1405.